Loda M - Search Results

1

MYC drives aggressive prostate cancer by disrupting transcriptional pause release at androgen receptor targets.

Qiu X, Boufaied N, Hallal T, Feit A, de Polo A, Luoma AM, Alahmadi W, Larocque J, Zadra G, Xie Y, Gu S, Tang Q, Zhang Y, Syamala S, Seo JH, Bell C, O'Connor E, Liu Y, Schaeffer EM, Jeffrey Karnes R, Weinmann S, Davicioni E, Morrissey C, Cejas P, Ellis L, Loda M, Wucherpfennig KW, Pomerantz MM, Spratt DE, Corey E, Freedman ML, Shirley Liu X, Brown M, Long HW, Labbé DP. Qiu X, et al. Among authors: loda m. Nat Commun. 2022 May 13;13(1):2559. doi: 10.1038/s41467-022-30257-z. Nat Commun. 2022. PMID: 35562350 Free PMC article.

2

Thymosin beta 15: a novel regulator of tumor cell motility upregulated in metastatic prostate cancer.

Bao L, Loda M, Janmey PA, Stewart R, Anand-Apte B, Zetter BR. Bao L, et al. Among authors: loda m. Nat Med. 1996 Dec;2(12):1322-8. doi: 10.1038/nm1296-1322. Nat Med. 1996. PMID: 8946830

3

Heterogeneity of androgen receptor content in advanced prostate cancer.

Magi-Galluzzi C, Xu X, Hlatky L, Hahnfeldt P, Kaplan I, Hsiao P, Chang C, Loda M. Magi-Galluzzi C, et al. Among authors: loda m. Mod Pathol. 1997 Aug;10(8):839-45. Mod Pathol. 1997. PMID: 9267828

4

Her-2-neu expression and progression toward androgen independence in human prostate cancer.

Signoretti S, Montironi R, Manola J, Altimari A, Tam C, Bubley G, Balk S, Thomas G, Kaplan I, Hlatky L, Hahnfeldt P, Kantoff P, Loda M. Signoretti S, et al. Among authors: loda m. J Natl Cancer Inst. 2000 Dec 6;92(23):1918-25. doi: 10.1093/jnci/92.23.1918. J Natl Cancer Inst. 2000. PMID: 11106683

5

Growth factor requirements and basal phenotype of an immortalized mammary epithelial cell line.

DiRenzo J, Signoretti S, Nakamura N, Rivera-Gonzalez R, Sellers W, Loda M, Brown M. DiRenzo J, et al. Among authors: loda m. Cancer Res. 2002 Jan 1;62(1):89-98. Cancer Res. 2002. PMID: 11782364

6

Loss of the Lkb1 tumour suppressor provokes intestinal polyposis but resistance to transformation.

Bardeesy N, Sinha M, Hezel AF, Signoretti S, Hathaway NA, Sharpless NE, Loda M, Carrasco DR, DePinho RA. Bardeesy N, et al. Among authors: loda m. Nature. 2002 Sep 12;419(6903):162-7. doi: 10.1038/nature01045. Nature. 2002. PMID: 12226664 Free article.

7

Fatty acid synthase expression defines distinct molecular signatures in prostate cancer.

Rossi S, Graner E, Febbo P, Weinstein L, Bhattacharya N, Onody T, Bubley G, Balk S, Loda M. Rossi S, et al. Among authors: loda m. Mol Cancer Res. 2003 Aug;1(10):707-15. Mol Cancer Res. 2003. PMID: 12939396

8

mTOR inhibition reverses Akt-dependent prostate intraepithelial neoplasia through regulation of apoptotic and HIF-1-dependent pathways.

Majumder PK, Febbo PG, Bikoff R, Berger R, Xue Q, McMahon LM, Manola J, Brugarolas J, McDonnell TJ, Golub TR, Loda M, Lane HA, Sellers WR. Majumder PK, et al. Among authors: loda m. Nat Med. 2004 Jun;10(6):594-601. doi: 10.1038/nm1052. Epub 2004 May 23. Nat Med. 2004. PMID: 15156201

9

Analysis of androgen regulated homeobox gene NKX3.1 during prostate carcinogenesis.

Korkmaz CG, Korkmaz KS, Manola J, Xi Z, Risberg B, Danielsen H, Kung J, Sellers WR, Loda M, Saatcioglu F. Korkmaz CG, et al. Among authors: loda m. J Urol. 2004 Sep;172(3):1134-9. doi: 10.1097/01.ju.0000136526.78535.b8. J Urol. 2004. PMID: 15311057

10

Androgen-induced differentiation and tumorigenicity of human prostate epithelial cells.

Berger R, Febbo PG, Majumder PK, Zhao JJ, Mukherjee S, Signoretti S, Campbell KT, Sellers WR, Roberts TM, Loda M, Golub TR, Hahn WC. Berger R, et al. Among authors: loda m. Cancer Res. 2004 Dec 15;64(24):8867-75. doi: 10.1158/0008-5472.CAN-04-2938. Cancer Res. 2004. PMID: 15604246

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

506 results

Search Page

Filters